Back
TuHURA Biosciences, Inc. HURA · Transcripts
website
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registrati...22
Price1.69
Market Cap108.6 M
Float45.2 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents